Publication

Journal

Patent

HOME Publication Journal

Journal

4

Discovery of Orally Bioavailable Phthalazinone Analogues as an ENPP1 Inhibitor for STING-Mediated Cancer Immunotherapy

Cho, Y. G.; Kang, M. S.; Ji, S. H.; Jeong, H. J.; Jung, J. E.; Oh, D. H.; Park, S. Y.; Park, Y.-Y.; Choi, J. H.; Kim, S. J.; Kim, N.-J.; Lee, D.-H.; Park, C. S.*; Han, S.-J.*; Lee, S. H.*; Choi, J. W.* 

J. Med. Chem. 2023, 66, 22, 15141-15170.



 LINK
3

Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease

Son, S. H.; Lee, N.-R.; Gee, M. S.; Song, C. W.; Lee, S. J.; Lee, S.-K.; Lee, Y.; Kim, H. J.; Lee, J. K.*; Inn, K.-S.*; Kim, N.-J.*

ACS Cent. Sci. 2023, 9, 3, 417-426.


 LINK
2

3ʹ,4ʹ-dihydroxyflavone mitigates inflammatory responses by inhibiting LPS and TLR4/MD2 interaction

Lee, H.-H.; Shin, J.-S.; Chung, K.-S.; Kim, J.-M.; Jung, S.-H.; Yoo, H.-S.; Hassan, Ahmed H.E.; Lee, J.K.; Inn, K.-S.; Lee, S.; Kim, N.-J.*; Lee, K.-T.*

Phytomedicine, 2023, 109, 154553.

 LINK
1

NJK14047 Suppression of the p38 MAPK Ameliorates OVA-Induced Allergic Asthma during Sensitization and Challenge Periods

Lee, J.-H.; Son, S.-H.; Kim, N.-J.; Im, D.-S.*

Biomol. Ther., 2023, 31(2), 183-192.

 LINK